BR9713537A - omo agonistas a alfa-2-adrenorreceptor - Google Patents

omo agonistas a alfa-2-adrenorreceptor

Info

Publication number
BR9713537A
BR9713537A BR9713537A BR9713537A BR9713537A BR 9713537 A BR9713537 A BR 9713537A BR 9713537 A BR9713537 A BR 9713537A BR 9713537 A BR9713537 A BR 9713537A BR 9713537 A BR9713537 A BR 9713537A
Authority
BR
Brazil
Prior art keywords
hydrogen
unsubstituted
alpha
dialkylamino
alkylamino
Prior art date
Application number
BR9713537A
Other languages
English (en)
Inventor
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9713537A publication Critical patent/BR9713537A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Patente de Invenção: <B>"COMPOSTOS DE 2-IMIDAZOLINRENORRECEPTOR"<D>. Esta invenção envolve compostosentre hidrogênio; C~ 1~-C~ 3~ alcanila, alquenila ou alquinila não substituído; cicloalcanila, cicloalquenila; C~ 1~-C~ 3~ alquiltio ou alcóxi não substituído; hidróxi; tio; nitro; ciano; amino; C~ 1~-C~ 3~ alquilamino ou C~ 1~-C~ 3~ dialquilamino e halo; b) R~ 4~ é selecionado entre hidrogênio; C~ 1~-C~ 3~ alcanila não substituído; amino, hidróxi, mercapto; C~ 1~-C~ 3~ alquiltio ou alcóxi; C~ 1~-C~ 3~ alquilamino ou C~ 1~-C~ 3~ dialquilamino e halo; c) R~ 5~ é hidrogênio; ou alquila ou nada; d) quando R~ 5~ for nada, a ligação (a) é uma dupla ligação; e) o grupamento imidazolinilamino está liómeros, isómeros ópticos, estereoisómeros, diaestereoisómeros, tautómeros, sais de adição, amidas e ésteres biohidrolisáveis dos mesmos, assim como composições farmacêuticas que compreendem tais novosto de perturbações moduladas por alfa-2 adrenorreceptores.
BR9713537A 1996-11-25 1997-11-21 omo agonistas a alfa-2-adrenorreceptor BR9713537A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3178796P 1996-11-25 1996-11-25
PCT/US1997/020803 WO1998023611A1 (en) 1996-11-25 1997-11-21 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Publications (1)

Publication Number Publication Date
BR9713537A true BR9713537A (pt) 2000-03-21

Family

ID=21861392

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713537A BR9713537A (pt) 1996-11-25 1997-11-21 omo agonistas a alfa-2-adrenorreceptor

Country Status (18)

Country Link
US (1) US6110952A (pt)
EP (1) EP0944622A1 (pt)
JP (1) JP2001506601A (pt)
KR (1) KR20000069128A (pt)
AU (1) AU736992B2 (pt)
BR (1) BR9713537A (pt)
CA (1) CA2272683A1 (pt)
CO (1) CO4910150A1 (pt)
CZ (1) CZ183699A3 (pt)
HU (1) HUP0002966A3 (pt)
ID (1) ID22060A (pt)
IL (1) IL130094A (pt)
NO (1) NO313755B1 (pt)
PE (1) PE16599A1 (pt)
SK (1) SK74999A3 (pt)
TR (1) TR199901486T2 (pt)
WO (1) WO1998023611A1 (pt)
ZA (1) ZA9710579B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713537A (pt) * 1996-11-25 2000-03-21 Procter & Gamble omo agonistas a alfa-2-adrenorreceptor
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
EP1812071A2 (en) * 2004-10-13 2007-08-01 PTC Therapeutics, Inc. Compounds for nonsense suppression, use of these compounds for the manufacture of a medicament for treating somatic mutation-related diseases
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US8283350B2 (en) * 2008-08-01 2012-10-09 Alpha Synergy Development, Inc. Compositions and methods for reducing capillary permeability
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
JP6052685B2 (ja) * 2011-07-25 2016-12-27 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ α２アドレナリン受容体の調節因子としてのＮ−（イミダゾリジン−２−イリデン）−ヘテロシクロペンタ［ｂ］ピリジン誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3830804A (en) * 1972-11-20 1974-08-20 Eastman Kodak Co Fluorescent(pyrimidinotriazolyl)-2-styrylbenzoxazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
FR2521140A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives d'imidazolidine, leur preparation et leur application en therapeutique
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
GB9110017D0 (en) * 1991-05-09 1991-07-03 Nat Res Dev Spectroscopic investigation using organometallic compounds
CA2181909C (en) * 1994-01-24 2008-10-07 Stephen A. Munk Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
CA2196792A1 (en) * 1994-08-04 1996-02-15 Yoon T. Jeon Novel benzimidazole derivatives
KR100215541B1 (ko) * 1996-04-19 1999-08-16 박원훈 벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
BR9713537A (pt) * 1996-11-25 2000-03-21 Procter & Gamble omo agonistas a alfa-2-adrenorreceptor

Also Published As

Publication number Publication date
NO313755B1 (no) 2002-11-25
CO4910150A1 (es) 2000-04-24
ZA9710579B (en) 1998-06-25
CZ183699A3 (cs) 1999-09-15
NO992500L (no) 1999-07-26
SK74999A3 (en) 2000-02-14
US6110952A (en) 2000-08-29
PE16599A1 (es) 1999-03-12
ID22060A (id) 1999-08-26
JP2001506601A (ja) 2001-05-22
AU736992B2 (en) 2001-08-09
EP0944622A1 (en) 1999-09-29
NO992500D0 (no) 1999-05-25
IL130094A (en) 2001-09-13
HUP0002966A2 (hu) 2001-09-28
TR199901486T2 (xx) 1999-10-21
CA2272683A1 (en) 1998-06-04
KR20000069128A (ko) 2000-11-25
HUP0002966A3 (en) 2001-10-29
IL130094A0 (en) 2000-02-29
WO1998023611A1 (en) 1998-06-04
AU5438298A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
BR9713537A (pt) omo agonistas a alfa-2-adrenorreceptor
BR9713542A (pt) Compostos de 2 - imidazolinilaminoindol úteis como agonistas do alfa - 2 - adrenoceptor
BR0010690A (pt) Composições de poliuretano-uréia contendo silìcio
BR9912945A (pt) Composições alcalinas de limpeza e desinfecção de superfìcies duras
HUP9900962A2 (hu) Fertőtlenítőkészítmények és eljárások felületek fertőtlenítésére
SI1663185T1 (sl) Preprečevanje in zdravljenje z vnetjem inducirane in/ali imunsko posredovane izgube kosti
BR9902086A (pt) Formulações farmacêuticas.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9914499A (pt) Agentes de proteção de colheitas ambientalmente benignas
YU65802A (sh) Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže
BR9814327A (pt) Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
MXPA04002382A (es) Combinaciones de herbicidas y antidotos.
BR9900443A (pt) Esteres de ácido aril acrìlico.
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
NZ294933A (en) Thienopyridine or thienopyrimidine derivatives, pharmaceutical compositions and use as anti-inflammatory agents
BR9406256A (pt) Processo para a preparação de uma composição aquosa desinfetante composição desinfetante sistema de duas embalagens para a preparação de uma composição desinfetante
BR9706629A (pt) Montagem de roda e pneu
NZ502988A (en) 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
UY25780A1 (es) Nuevos antibióticos macrólidos
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
BR9713536A (pt) Compostos heterocìclicos de guanidinila úteis como agonistas de adrenoceptores alfa-2
BR9916423A (pt) Formulação de baixo ponto de congelamento contendo fenol e/ou derivados de fenol
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0113634A (pt) Antibióticos de cefalosporina e suas pró-drogas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1817 DE 01/11/2005 POR TER SIDO APRESENTADA PAPELETA DE ESCLARECIMENTO.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE, DE ACORDO COM ART. 36 DA LPI (LEI 9279/96).